Pfizer Inc. Selling Vaccine Against Deadly Infections to Poor Countries Cheaply in Special Program

Published: Jul 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drugmaker Pfizer Inc. has agreed to provide hundreds of millions of doses of its lucrative vaccine against pneumonia and meningitis at a fraction of the usual price for young children in poor countries. The deal to provide 260 million shots of its Prevnar 13 vaccine for a few dollars each is Pfizer’s third agreement under an innovative program through which pharmaceutical companies, governments, health groups and charities collaborate to bring poor countries a long-term supply of affordable vaccines against deadly diseases.

Help employers find you! Check out all the jobs and post your resume.

Back to news